SLG
TRIL

Stanley-Laman Group’s Trillium Therapeutics Inc. TRIL Stock Holding History

Stanley-Laman Group’s Portfolio TRIL Stock Details TRIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-139,403
Closed -$809K – 308
2018
Q3 		$809K Buy
139,403
+2,312
+2% +$13.4K 0.2% 154
2018
Q2 		$823K Buy
137,091
+28,907
+27% +$174K 0.18% 163
2018
Q1 		$779K Buy
+108,184
New +$779K 0.18% 165